Longevity Today
Academic PapersReviewsVideosPodcastsPress ReleasesClinical TrialsDrug ApprovalsTutorialsAnimations
All Articles
Sign In
Deep Dive Audio
HPV Cancers Four Times More Likely in HIV Patients and Transplant RecipientsLongevity & Aging

HPV Cancers Four Times More Likely in HIV Patients and Transplant Recipients

A large Swedish retrospective study found that people with HIV are over four times more likely to develop HPV-related cancers compared to healthy matched controls, while organ transplant recipients face more than double the risk. The cancers studied include anal, penile, vulvar, and cervical cancers. Researchers from the Karolinska Institutet analyzed data from over 350,000 individuals spanning four decades. The findings highlight how long-term immune suppression — whether from HIV or anti-rejection medications — impairs the body's ability to clear HPV infections and prevent precancerous lesions from progressing. Experts call for earlier vaccination, better screening, and optimized immunosuppressive regimens in these high-risk groups.

0:00--:--
Read Full Article
Longevity Today

Developed by the Clinical and Foundational Medicine Institute

AI-powered summaries of the world's best longevity research — from peer-reviewed journals to expert podcasts and YouTube deep-dives. Built for those who take their healthspan seriously.

info@LongevityToday.com

Categories

CancerHeart DiseaseAlzheimer'sParkinson'sDiabetesGut HealthNutritionStrength & FitnessSupplements & PeptidesStem CellsReversing AgingAuto-ImmunityAdvanced Therapies

Platform

  • All Articles
  • Membership Plans
  • Search
  • Newsletter

Newsletter

Weekly longevity research, summarized.

Enter your email to subscribe:

© 2026 Longevity Today. All rights reserved.

About UsPrivacy PolicyTerms of UseMedical Disclaimer

Content on Longevity Today is for informational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before making health decisions.